Your search returned 4 results.

Results
	1.	Current evidence of temozolomide and bevacizumab in treatment of gliomas. [electronic resource] by Nanegrungsunk, Danop Onchan, Wimrak Chattipakorn, Nipon Chattipakorn, Siriporn C Producer: 20151215 In: Neurological research vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Heparanase promotes neuroinflammatory response during subarachnoid hemorrhage in rats. [electronic resource] by Changyaleket, Benjarat Chong, Zhao Zhong Dull, Randal O Nanegrungsunk, Danop Xu, Haoliang Producer: 20180411 In: Journal of neuroinflammation vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors. [electronic resource] by Nanegrungsunk, Danop Apaijai, Nattayaporn Yarana, Chontida Sripetchwandee, Jirapas Limpastan, Kriengsak Watcharasaksilp, Wanarak Vaniyapong, Tanat Chattipakorn, Nipon Chattipakorn, Siriporn C Producer: 20170113 In: Neurological research vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	VAP-1 blockade prevents subarachnoid hemorrhage-associated cerebrovascular dilating dysfunction via repression of a neutrophil recruitment-related mechanism. [electronic resource] by Xu, Haoliang Testai, Fernando D Valyi-Nagy, Tibor N Pavuluri, Mani Zhai, Fengguo Nanegrungsunk, Danop Paisansathan, Chanannait Pelligrino, Dale A Producer: 20151207 In: Brain research vol. 1603 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)